Isis heart drug leads to big reduction in blood fat

AMSTERDAM (Reuters) - An experimental drug from Isis Pharmaceuticals produced a sharp reduction in levels of triglycerides, a type of fat in the blood that increases the risk of heart disease, a small mid-stage trial showed. Codenamed ISIS-APOCIIIRx, the drug is attracting increased attention from investors who believe it could be a big money spinner for the U.S. biotech company. It is designed for patients with very high to severely high triglyceride levels. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/isis-heart-drug-leads-big-reduction-blood-fat-100932122--finance.html